DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance
FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III, to Vice President Business Development and Corporate Finance. Mr.
Lea was most recently Director of Corporate Development and Finance for the company.
"Since joining DFB...
Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb
...mity amputation
(LEA). In addition, nearly half of all patients who undergo
lea will
ultimately require an amputation of the opposite limb within 5 years. ...nts in the U.S. is over 80,000 annually. The 3-year mortality
rate after an
lea is between 35 and 50 percent. Despite the advancement of
increasingly sophi...
A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology
...ardiman, "Microarray technologies - an overview," Pharmacogenomics 3 (3), pp. 1-5, 2002.
36. J. B. Walter, Pathology of Human Disease,
lea & Febiger, Philadelphia, 1989.
37. O. Kallioniemi, U. Wagner, J. Kononen, and G. Sauter, "Tissue microarray technology for high-throughput ...